In 2023, the trade exchange (includes international purchases and sales) of Vitamin B2 and Derivatives Primarily as Vitamins was US$5.18M.
In 2023, the states with the most international sales in Vitamin B2 and Derivatives Primarily as Vitamins were Jalisco (US$250k).
The states with the most international purchases in 2023 were Jalisco (US$2.51M), Ciudad de México (US$1.29M), Estado de México (US$717k), and Querétaro (US$109k).
In 2023, the main commercial destinations of Vitamin B2 and Derivatives Primarily as Vitamins were El Salvador (US$69.8k), Jamaica (US$46.2k), Barbados (US$41.4k), Haiti (US$22.5k), and Dominican Republic (US$22k).
The main commercial origins of Vitamin B2 and Derivatives Primarily as Vitamins in 2023 were Germany (US$1.73M), China (US$1.3M), South Korea (US$1.15M), France (US$367k), and India (US$71.9k).
In the global context, the main exporting countries of Vitamin B2 and Derivatives Primarily as Vitamins in 2022 were China (US$71.5M), Germany (US$66.7M), and Netherlands (US$62.1M). In the same year, the main importing countries of Vitamin B2 and Derivatives Primarily as Vitamins were United States (US$50.4M), Germany (US$28.2M), and France (US$19.8M).